MCPH1 alterations have also been reported in TCGA datasets retrieved from cBioPortal Cancer Genomics database [30], not only in breast tumors (about 7%) but also in other malignancy types observed in the currently identified carrier families (sarcomas 3.5%, brain tumors 1% and lung cancer 8%). Here, MCPH1 is linked to breast neoplasm.